To help you get the best out of your visit to the
Biochemical Journal, papers are divided into nine knowledge environments:
Cell,
ChemBio,
Disease,
Energy,
Gene,
Metabolism,
Plant,
Signal,
Structure
With an Impact Factor of 5.016 there has never been a better time to submit your next paper to us.
Submit your next paper and find out what publishing
benefits we offer...
San Diego, February 25-29
Visit us at Booth #333 for your chance to win an Apple iPad 2!
US Symposium, March 22nd 2012 - Free Registration
In gratitude to the Sanford-Burnham Medical Research Institute for hosting its US Editorial Office, the
Biochemical Journal is sponsoring a special one-day symposium at the Institute in La Jolla, CA on Thursday March 22nd 2012.
View speaker list and pre-register.
SEMANTIC BJ VIDEO DEMO
The
Semantic Biochemical Journal brings PDFs to life and will revolutionize the way we interact with the scholarly scientific journal forever. See the revolution for yourself -
video demo now available
In this BJ Disease paper, which is freely available to all readers, Bart Vanhaesebroeck and colleagues present results which show that inactivation of either p110α or p110β of PI3K (phosphoinositide 3-kinase) can counteract the impact of inactivation of the tumour suppressor PTEN (phosphatase and tensin homologue deleted on chromosome 10).
In this BJ Signal paper, which is freely available to all readers, Christopher Proud and colleagues provide the first insights into the allosteric control of eEF2K (eukaryotic elongation factor 2 kinase), and propose a model for the functional organization and control of eEF2K.
In this BJ Metabolism paper, Peter Shepherd and colleagues have investigated the effects of a range of inhibitors with varying specificity for class-I PI3K (phosphoinositide 3-kinase) isoforms and mTOR (mammalian target of rapamycin) on whole-body glucose metabolism in mice, and provide pharmacological evidence to support a pre-eminent role for the p110α isoform of PI3K in pathways that acutely regulate glucose metabolism.